跳至主要内容
临床试验/NCT05334758
NCT05334758已完成不适用

Clinical Performance Evaluation of the Bio-Self™ COVID-19 Antigen Home Test

BioTeke USA, LLC6 个研究点 分布在 1 个国家目标入组 282 人开始时间: 2022年5月12日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
282
试验地点
6
主要终点
Positive Percent Agreement - Sensitivity

研究概览

简要总结

The purpose of this study is to evaluate the performance of the Bio-Self COVID-19 Antigen Home Test. The study will evaluate the accuracy (sensitivity and specificity) in a simulated home use environment when compared to a high-sensitivity Emergency Use Authorization (EUA) SARS-CoV-2 RT-PCR assay.

详细描述

The Bio-Self COVID-19 Antigen Home Test is immunochromatographic and uses double-antibody sandwich method to detect SARS-CoV-2 antigen from individuals with or without symptoms or other epidemiological reasons to suspect a COVID-19 infection. The test is intended for non-prescription home use with self-collected direct anterior nares swab samples from individuals ages 14 years and older or adult collected anterior nares swab samples from individuals ages 2 to 13.

The primary objective of this study is to determine the accuracy of the Bio-Self COVID-19 Antigen Home Test when compared to a high-sensitivity Emergency Use Authorization (EUA) SARS-CoV-2 RT-PCR assay.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
2 Years 至 94 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • An Institutional Review Board (IRB) approved informed consent and assent, if applicable, is signed and dated prior to any study-related activities.
  • Male and female Subjects 2 years of age and older.
  • Subject is willing to provide a self-collected nasal swab sample. (If under the age of 14, the sample will be collected by an adult.)
  • Subject is willing to have a nasal swab collected by a healthcare professional.
  • Subject agrees to complete all aspects of the study.

排除标准

  • Subject has a visual impairment that cannot be restored with glasses or contact lenses.
  • Subject has prior medical or laboratory training.
  • Subject had a positive COVID-19 test in past three (3) months.
  • Subject uses home diagnostics, e.g., HIV Tests, glucose meters, etc.

结局指标

主要结局

Positive Percent Agreement - Sensitivity

时间窗: 48 hours

The sensitivity is computed as the proportion of positive samples as called by the EUA SARS-CoV-2 RT-PCR assay, which are also positive as called by the Bio-Self COVID-19 Antigen Home Test.

Negative Percent Agreement - Specificity

时间窗: 48 hours

The specificity is computed as the proportion of negative samples as called by the EUA SARS-CoV-2 RT-PCR assay, which are also negative as called by the Bio-Self COVID-19 Antigen Home Test.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验

Clinical Performance Evaluation of the Bio-Self™... | 临床试验